Fig. 2From: Nanotechnology and cancer: improving real-time monitoring and staging of bladder cancer with multimodal mesoporous silica nanoparticlesFunctionalized mesoporous silica nanoparticles (MSN) are taken up by mouse bladder cancer cells. Flow cytometry for MB49 bladder cancer cells exposed to 100 μg/mL PEG–Gd2O3–TRITC–MSN. a MB49-Luc+ cells were used as negative controls for both GFP and TRITC. b MB49-GFP+ cells prior to labeling were 99.8 % GFP+/TRITC−. c After labeling, 69.6 % of the cells were found to be GFP+/TRITC+, with a range of levels of rhodamine fluorescence, indicating some cells picked up more MSN particles than othersBack to article page